Clarence Dunn, MD
Gastroenterology · West Monroe, LANPI 1770673568
Payments from drug & device makers
Across 758 payments — averaging $1529.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$448K
- Braintree Laboratories, Inc.$246K
- Ironwood Pharmaceuticals, Inc$222K
- Novartis$109K
- Madrigal Pharmaceuticals$77K
- Ipsen Bioscience Inc.$38K
- plus $19K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 234 | $447,724 |
| Braintree Laboratories, Inc. | 59 | $246,305 |
| Ironwood Pharmaceuticals, Inc | 35 | $221,871 |
| Novartis | 4 | $109,498 |
| Madrigal Pharmaceuticals | 27 | $76,694 |
| Ipsen Bioscience Inc. | 30 | $38,178 |
| Shire North American Group Inc | 3 | $7,429 |
| Adare Pharmaceuticals, Inc. | 6 | $4,403 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 256 | $2,495 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $2,193 |
| Eli Lilly | 1 | $934 |
| Olympus America Inc. | 8 | $338 |
| Ardelyx, Inc. | 8 | $291 |
| Redhill Biopharma Inc. | 23 | $198 |
| Phathom Pharmaceuticals, Inc. | 8 | $173 |
| Merck | 11 | $159 |
| Johnson & Johnson | 9 | $120 |
| Ipsen Biopharmaceuticals, Inc | 2 | $84 |
| Evoke Pharma, Inc. | 4 | $70 |
| QOL Medical, LLC | 2 | $55 |
| Ferring Pharmaceuticals Inc. | 2 | $43 |
| Intercept Pharmaceuticals, Inc. | 3 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $38 |
| Sanofi | 2 | $37 |
| Alfasigma USA, Inc. | 1 | $33 |
| Bristol Myers Squibb | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Celltrion USA Inc. | 1 | $14 |
How this compares
$1,159,463 in reported general payments places this provider in the 95th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in West Monroe
- Humberto AguilarShreveport$13.1M
- Gary ReissMarrero$10M
- Bal BhandariBastrop$6.4M
- Gregory GaspardBaton Rouge$4M
- Jonathon ChapmanBaton Rouge$3.6M
- David DulitzLuling$1.9M
- Conar FittonKenner$1.6M
- Vivek HuilgolNew Orleans$1.6M
- Georges CatinisMetairie$1.3M
- Sarah GloverNew Orleans$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.